Founded by an accomplished gastroenterologist, AI Medical Service is determined to contribute to the detection of early cancer in the digestive tract by leveraging a CNN deep learning algorithm. Venture Valuation (VV) interviewed Tomohiro Tada, Founder and CEO. Read the interview Would you like to be notified about new interviews, reports and other valuable content … Continue reading Interviews with leading Life Sciences companies: AI Medical Service Inc.
Founded by four experts in laser physics, medical image analysis, and cranio-maxillofacial surgery, AOT is reinventing the bone surgery field with laser osteotomy technology: CARLO® (Cold Ablation Robotguided Laser Osteotome).
It is no surprise that most biotech investors are based in the US. But, do they invest exclusively in American companies? Read the report Would you like to be notified about new articles, reports and other valuable content published by Venture Valuation?
Applying intelligently glycemic control and a systematic route through the BBB (blood-brain barrier) to effectively reach neurons. Venture Valuation (VV) interviewed the CEO, Mariko Tosu, PhD
The US Internal Revenue Code has numerous regulations which must be adhered to in order for companies to reach compliance standards. One such regulation, Section 409A of the IRC, governs the complexities of setting strike prices for employee stock options and requires that companies be properly audited before issuing stock options as employee compensation. Often … Continue reading Whitepaper: Life Sciences – 409A valuation vs. valuation to raise money
Zurich, 25th March 2019 Biotechgate announces the launch of a clinical trial database with more than 460,000 trial records. Clinical trial data is imported from more than 13 registries around the world and continuously updated and catalogued. Thanks to the use of newly developed smart software components, the data is presented in a well-structured and … Continue reading Biotechgate announces the launch of a clinical trial database
Switzerland, March 2019: Venture Valuation has been working with Ferring Pharmaceutical supporting the company with external, third-party product/asset valuations of potential in-licensing opportunities. After Ferring had identified a specific opportunity and deemed interesting to move it forward in the internal evaluation process, Venture Valuation was mandated to review the product/opportunity from an external point of … Continue reading Whitepaper: Collaboration of Venture Valuation and Ferring Pharmaceuticals
Inspired by co-founder Lea von Bidder’s concept, the Ava bracelet is becoming an indispensable device for women to monitor their own biological rhythms. Venture Valuation (VV) interviewed Vicky Kummer, Global Brand Manager. Read the interview Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?
Zurich/Berlin, January 2019; Venture Valuation entered into a partnership with HEALTH MADE IN GERMANY, the export promotion program for the German healthcare industry initiated by the German Federal Ministry for Economic Affairs and Energy. HEALTH MADE IN GERMANY is implemented by Germany Trade & Invest (GTAI), the country’s economic development agency. It is Venture Valuation’s … Continue reading Biotechgate, HEALTH MADE IN GERMANY and Germany Trade & Invest (GTAI) to map German Life Science Industry
14 January 2019. Last week saw the annual J.P. Morgan Healthcare Conference held in San Francisco. Venture Valuation and Biotechgate was represented by CEO, Patrik Frei and Senior Business Development Executive Ray Carroll providing their insights into the industry announcements. It was again a busy week in San Francisco kicking off the Bio year 2019 … Continue reading J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate
